Introduction
Meis1 (Myeloid Ecotropic viral Integration Site 1), a homeobox gene, was identi®ed as a site of viral integration that is common to 15% of myeloid tumors arising in the BXH-2 recombinant inbred strain of mice (Moskow et al., 1995) . Aberrant Meis1 gene expression is involved in the pathogenesis of these tumors and the gene is located in a region known to contain translocations found in human leukemias (2p23-p12). Within the homeodomain, Meis1 is closely related to the Pbx gene family and belongs to the TALE (three amino acid loop extension) superclass of homeodomain proteins (Burglin, 1997; Steelman et al., 1997) . Pbx1 was identi®ed as a fusion partner with E2A in a translocation breakpoint found in human pre-B-cell leukemias (Kamps et al., 1990; Nourse et al., 1990) .
It has recently been shown that Meis (Chang et al., 1997; Ryoo et al., 1999) and Pbx (Lu et al., 1995; Neuteboom et al., 1995; Phelan et al., 1995 , Chang et al., 1996 are cofactors for the Hox proteins and augment the anity and speci®city of DNA binding by Hox proteins. In mammals, while the majority of Hox proteins interact with Pbx (Hox paralogs 1 ± 10) (Chang et al., 1995; Neuteboom et al., 1995; Phelan et al., 1995) , only the group 9 and 10 Abd-B class Hox proteins complex with Meis (Shen et al., 1997) . Meis, Pbx, and Hox family members have also been reported to form trimeric complexes in vivo (Berthelsen et al., 1998; Swift et al., 1998; Jacobs et al., 1999; Shanmugam et al., 1999; Shen et al., 1999) .
In addition to Meis, Pbx and some Hox proteins have been implicated in leukemias of mice and humans (Blatt et al., 1988; Kamps et al., 1990; Nourse et al., 1990; Perkins et al., 1990; Moskow et al., 1995; Thorsteinsdottir et al., 1997a,b; Nakamura et al., 1996; Kawagoe et al., 1999; Lawrence et al., 1999) . In BXH-2 mice, HoxA9 and HoxA7 were found to be targets of viral integration in 95% of tumors with a Meis1 integration (Nakamura et al., 1996) . Meis1 is able to cooperate with HoxA9 to transform mouse primary bone marrow cells, and both HoxA9 and Meis1 are frequently found co-expressed in myeloid leukemic cells (Kroon et al., 1998; Lawrence et al., 1999) . Beside their role in oncogenesis, homeodomain proteins have been shown to play an integral role in determining embryonic axes, segmental identity and regulating cell dierentiation (McGinnis and Krumlauf, 1992 ; Levine and Hoey, 1988) .
In Drosophila, Meis has been implicated as a key regulator in several developmental processes. The Drosophila Meis homolog, homothorax (hth), cooperates with extradenticle (Exd), a Drosophila Pbx homolog, to control antenna determination (Casares and Mann, 1998) , patterning of the embryonic¯y peripheral nervous system (Salzberg et al., 1994; Kurant et al., 1998) , and the suppression of eye development . The interaction between Hth and Exd triggers the nuclear localization of Exd, thus allowing for proper function of the protein complex Kurant et al., 1998; Rieckhof et al., 1997; Abu-Shaar et al., 1999; Berthelsen et al., 1999) . While Meis genes are extremely conserved throughout evolution from C. elegans to humans (Steelman et al., 1997; Burglin, 1997) , their function in vertebrates is only beginning to emerge. Recent evidence in chicken suggests that restriction of Meis1 to proximal regions of the limb is essential for the speci®cation of cell fates along the proximal-distal axis of the limb (Mercader et al., 1999) .
The Xenopus embryo is well suited for investigations of developmental and cellular processes because of its well characterized invariant cell fate map and the ability to assess the functional eects of proteins on developmental pathways. Recently, a cDNA encoding Meis3, a Meis family member with 67% amino acid identity to Meis1, was isolated from Xenopus (Salzberg et al., 1999) . Xmeis3 was expressed in the hindbrain and anterior spinal cord in the developing frog. Ectopic expression in the developing embryo resulted in the caudalizing of neural tissue in the absence of neural induction, suggesting a role for this protein in anterior to posterior patterning in the nervous system (Salzberg et al., 1999) .
In a previous paper, we isolated a Xenopus homolog of Meis1 (Xmeis1), and showed that the Meis1 gene is highly conserved throughout its coding region as well as the 3' untranslated region (Steelman et al., 1997) . There are two alternative splice variants, Xmeis1a and Xmeis1b, that dier only in the resulting C-terminus of the proteins (Moskow et al., 1995; Steelman et al., 1997) . However, their roles have not been elucidated as yet. In the present study we examine the expression and function of Xmeis1 in the developing Xenopus embryo. This study reveals a role for Xmeis1 in specifying neural crest cell fate, and the induction of ectopic cell masses when inappropriately expressed.
Results

Expression pattern of Xmeis1 suggests a role in neural crest development
In an eort to understand where and when Xmeis1 may function, we examined the expression of Xmeis1 transcripts in adult tissues and in various developmental stages. Northern analysis was performed using a Xmeis1 cDNA probe on RNA from dierent adult tissues of Xenopus laevis. This analysis indicates broad expression of Xmeis1 across many adult organs with the highest expression observed in brain, and spleen ( Figure 1a) . In a previous report, we showed that two alternatively spliced forms (Xmeis1a and Xmeis1b) of Xmeis1 transcripts exist in Xenopus, and the resulting translational products dier only in the C-terminal region of the proteins (Moskow et al., 1995; Steelman et al., 1997) . To examine whether Xmeis1a and Xmeis1b demonstrate dierent temporal expression during embryogenesis, we made speci®c PCR primers for Xmeis1a and Xmeis1b, respectively. In the course of development, Xmeis1a and Xmeis1b transcripts appeared as maternally-derived mRNAs. Xmeis1b transcripts only slightly transiently decreased during gastrulation (stage 12), but showed a marked accumulation during neurulation and throughout embryogenesis. In contrast, the expression of Xmeis1a remained low during earlier stages, and increased after tailbud stages (stage 28) (Figure 1b) , suggesting a possible dierence in function of these two transcripts.
To determine the spatial expression of Xmeis1 during development, whole-mount in situ hybridization was performed. Very faint broad expression was detected early but became more pronounced within the developing neural folds at the early neurula stage (stage 14) (Figure 2a) . At stage 15, expression is more prominent in the anterior region across the neural plate, as a distinct transverse stripe of cells in the prospective mid-brain region, and dorsally along the neural folds (Figure 2b ). At stage 20/21, expression is Figure 1 Spatial and temporal distribution of Xmeis1 RNA expression in adult tissues (a) and developmental stages of embryos (b). (a) Northern blot analysis of RNA extracted from the adult tissues a Xmeis1 speci®c probe. The 18S RNA probe was used as a loading control. (b) RNA was extracted from embryos from indicated stages, RT ± PCR gene analysis was performed for Xmeis1a and Xmeis1b speci®c primers. Histone H4 primer was used as a loading control. PCR performed without cDNA is indicated as`Neg' Xmeis1 specifies neural cell fate R Maeda et al prominent within the neural folds and hybridization is also strong in the midbrain, hindbrain, and the optic cup ( Figure 2c ). As development proceeds (stage 24), Meis1 expression increases within the midbrain (mesencephalon), hindbrain (rhombencephalon), optic cup, and along the dorsal portion of the neural tube ( Figure 2d ). By stage 28, the olfactory placode, optic cup, otic vesicle, branchial arches, and spinal cord are strongly expressing Meis1 (Figure 2e ). Transverse sections through the late stage embryo con®rm expression in the dorsal portion of the neural tube ( Figure 2f ). Thus, the enhanced expression of Xmeis1 occurs in developing neural tissue in a spatially restricted manner. The expression pattern suggests that Xmeis1 may have a role in the dorsal speci®cation of neural tissue, or patterning of the anterior ± posterior axis of embryos.
Xmeis1b induced neural and neural crest cell markers in ectodermal explants, in the absence of mesoderm
Having established the expression pattern of Xmeis1 transcripts and the possible implication of a role in the developing neural tissue, we next investigated whether Xmeis1a and Xmeis1b could have a functional in¯uence on cell fate in embryonic ectodermal explants. We examined the expression of neural and mesodermal tissue markers by RT ± PCR in animal pole explants from embryos injected with Xmeis1a or Xmeis1b. Xmeis1b induced a pan-neural marker, N-CAM, a pan-neuron marker, N-tubulin, and a neural crest cell marker, Xtwist (Hopwood et al., 1989) . Xmeis1b also markedly induced Krox-20 (hindbrain and late neural crest marker), a transcription factor that controls certain neural crest genes (Papalopulu et al., 1991; Theil et al., 1998) while, weakly inducing an anterior neural marker, Otx-2 (Figure 3a) . In contrast to Xmeis1b, high concentrations of Xmeis1a (5 ng/embryo) only weakly induced most markers (Figure 3a) . Explants from embryos left uninjected, or injected with an Xmeis1b truncation mutant did not display induction of these markers (Figure 3a , data not shown). While, Xmeis1a was much less eective than Xmeis1b at inducing most neural markers, it was able to induce a slight increase in Otx-2 expression, which was comparable to Xmeis1b. We also tested whether Xmeis1a or Xmeis1b induced mesodermal markers in the animal pole explants, since it was possible that the neural crest induction could be the result of forming mesodermal tissue. Neither Xbrachyury (early mesodermal marker) nor muscle actin (late mesodermal marker) transcripts were induced by these products (Figure 3a,b) . These results indicate that Xmeis1b is involved in the speci®cation of neural cell fate, particularly neural crest tissues in the absence of mesoderm.
Xmeis1 protooncogene activates the Gli/Zic pathway in ectodermal explants
Having established that Xmeis1b can induce some early and late neural crest markers in an explant system, we next tested whether Xmeis1a and Xmeis1b could also induce pre-pattern genes that have been postulated to play an important role in neural crest induction subsequent to neuralization. Zic3, a member of the Gli gene superfamily (Brewster et al., 1998) , is a prepattern gene that also induces pigmented cell masses in Xenopus embryos and promotes the earliest steps in neural and neural crest development (Nakata et al., 1997) . Therefore, it was of interest to determine whether the Xmeis1 protooncogene could activate the Gli/Zic pathway. We examined the expression of XGli-1, XGli-3, and XZic3 by RT ± PCR in the animal pole explants from embryos injected with Xmeis1a or Xmeis1b RNA. As a result, XGli-3 and XZic3 were strongly induced in response to Xmeis1b, while XGli-1 was not induced in the animal caps (Figure 4 ). It should be noted that XGli-3 mRNA can be detected in ectodermal explants, but there is a clear induction of XGli-3 transcripts in response to Xmeis1b expression ( Figure 4 ). In contrast, Xmeis1a showed a weak ability to activate XGli-3 and XZic3. These data suggest that Xmeis1b may function through the activation of the Gli/Zic pathway, and that there is speci®city regarding which Gli superfamily members are induced. Ectopic expression of XZic3 in animal caps did not up-regulate Xmeis1 expression, suggesting that Xmeis1 may function upstream of XZic3 (data not shown).
To further determine whether XZic3 induction is an early response to Xmeis1b activity, we generated an inducible Meis1b protein where the glucocorticoid hormone-binding domain is fused to Xmeis1b Figure 3 Xmeis1b induces neural and neural crest markers in animal cap explants in the absence of mesoderm. (a) The animal pole region of two-cell stage embryos were injected with Xmeis1a (2.5 ng or 5 ng/embryo), Xmeis1b (2.5 ng, or 5 ng/embryo) RNAs. Animal pole explants were excised at stage 9 and cultured until stage 26. RT ± PCR gene analysis was performed for N-CAM (pan-neural marker), N-tubulin (pan-neuronal marker), Xtwist (neural crest cell marker), Otx-2 (forebrain marker), Krox-20 (hindbrain and late neural crest marker), HoxB9 (spinal cord marker), muscle actin (dorsal mesodermal marker), and EF1a (loading control). Note that Xmeis1b induced stronger expression of neuronal and neural crest cell markers than Xmeis1a. Krox-20 was strongly induced by Xmeis1b. (b) The animal pole region of two-cell stage embryos were injected with Xmeis1a (5 ng/embryo), Xmeis1b (5 ng/embryo), or eFGF (1.0 ng/ embryo) RNAs. Animal pole explants were excised at stage 9 and cultured until stage 11 or stage 26. For activin treatment (12 ng/ ml), animal pole explants from uninjected embryos were excised at stage 8. RT ± PCR gene analysis was performed for mesodermal markers, Xbrachyury (Xbra, early pan-mesodermal marker-stage 11), muscle actin (late mesodermal marker-stage 26), Histone H4 (loading control). Stage 22 embryonic RNA with or without reverse transcriptase (RT+or 7) was also used as a positive and negative reaction control Figure 4 Xmeis1b expression induces the Gli/Zic pathway in ectodermal explants. The animal pole region of two-cell stage embryos were injected with Xmeis1a (2.5 ng, or 5 ng/embryo), Xmeis1b (2.5 ng, or 5 ng/embryo) RNAs. Animal pole explants were excised at stage 9 and cultured until stage 11. RT ± PCR gene analysis was performed for XGli-1 (shh signaling, ventral neural tube), XGli-3 (shh signaling, dorsal neural tube), XZic3 (proneural and neural crest), and EF1-a (loading control). Note that Xmeis1b induces XGli-3 and XZic3 expression, but not XGli-1 (Xmeis1bGR). Xenopus embryos were either injected with Xmeis1bGR RNA (6 ng/embryo) or left uninjected, and explants were prepared from blastula stage embryos. The explants were cultured either in the presence of dexamethasone or left untreated for various times. We then examined the induction of three genes, XZic3 (a prepattern gene), XASH-3 (a proneural gene induced by XZic3 expression) (Zimmerman et al., 1993) , and Krox-20 (a transcription factor found in rhombomeres 3 and 5, and migrating neural crest cells). After 24 h of culturing Xmeis1bGR-expressing explants in the presence of hormone, there is an induction of XZic3, XASH-3, and very strong expression Krox-20 (Figure 5a ). In contrast, within 2 h of Xmeis1bGR activation, there is strong expression of XZic3, XASH-3, and only weak expression of Krox-20 that is consistent with its later role in neural crest development ( Figure 5a ). Finally, we examined the pattern of expression of these three genes after only 30 min of hormone treatment and found that XZic3 was strongly induced when compared to XASH-3 and Krox-20, suggesting that XZic3 induction is an early response to Xmeis1bGR activation, which is then followed by XASH-3 and lastly, Krox-20 ( Figure 5b ). This data is consistent with the reported temporal order of expression of these genes in vivo (Mayor et al., 1999 review) , and suggests that Xmeis1b may be involved in early neural crest patterning.
Injection of Xmeis1b induced tumor-like ectopic pigmented cell accumulation
Since we established that Xmeis1b could induce XZic3 in ectodermal explants, we next tested whether Xmeis1b induced ectopic pigmented protuberances, a morphological eect observed with the overexpression of XZic3 (Nakata et al., 1997) . We injected synthesized Xmeis1a (2.5 ng/embryo) or Xmeis1b (2.5 ng/embryo) RNA into one blastomere of two-cell stage embryos and allowed them to develop until stage 26. The embryos injected with Xmeis1b RNA formed a mass of ectopic pigmented cells on the lateral side at a very high frequency (Table 1, Figure 6c ). Xmeis1b was more eective at inducing cell masses than Xmeis1a (Table 1 , Figure 6b ), despite equivalent levels of protein expression as judged by Western analysis (Figure 6d ). Xmeis1a injected at higher concentrations (5 ng/ embryo) induced pigmented cell masses in 28% of embryos and the masses were smaller than that of Xmeis1b (Table 1 , data not shown). Transverse sections of Xmeis1b injected embryos showed that the cell masses accumulated in ectoderm-derived cells, but not mesoderm-or endoderm-derived cells (Figure 7b,d,f) . In addition to the ectodermal region, the cell masses accumulated adjacent to the lateral edge of the neural tube and have signi®cant in®ltration of pigmented cells and darker hematoxylin staining neural-like cells (Figure 7e ± i) . A control injection of RNA encoding a truncated mutant of the Xmeis1b protein (resulting from a frameshift upstream of the homeodomain region) showed no phenotypic abnormalities (Table 1) .
To examine whether overexpression of Xmeis1b aected the normal distribution of cells, b-galactosidase RNA was co-injected as a lineage tracer along with A B Figure 5 Activation of Xmeis1bGR rapidly induces XZic3 expression in ectodermal explants. The animal pole region of two-cell stage embryos were injected with Xmeis1bGR (a dexamethasone activatable Xmeis1b/Glucocorticoid Receptor binding domain fusion protein, 6 ng/embryo) RNA. Animal pole explants were excised at stage 9 and cultured for 2 and 24 h (a), or 30 min and 2 h (b) in the presence (+) or absence (7) of dexamethasone (DEX). RT ± PCR gene analysis was performed for XZic3 (proneural and neural crest), XASH-3 (proneural), and Krox-20 (hindbrain, late neural crest), and Histone H4 (loading control). Note: (a) XZIc3, and XASH-3 are induced within 2 h, while Krox-20 is strongly induced within 24 h. (b) XZic3 is induced within 30 min while, XASH-3 and Krox-20 are only weakly induced in this time period Xmeis1b. One ventral/animal blastomere of eight-cell stage embryos was injected with b-galactosidase RNA alone, or co-injected with Xmeis1b RNA, and the embryos were allowed to develop until stage 26. In this case, the ectopic pigmented cells were induced in the ventral/lateral region of the embryo. The vast majority of these cells were positive for X-Gal staining, but the b-galactosidase expression was not restricted to the tumor-like area (Figure 8 ). Moreover, in the Xmeis1b RNA-injected embryos, the majority of b-galactosidase staining is concentrated in the pigmented cell mass, while the embryos injected only with b-galactosidase RNA display a diuse staining pattern throughout the ventral/lateral side of the embryo (Figure 8 ). This data suggests that the pigmented protrusions represent a subset of cells recruited to or migrating into the cell mass rather than a clonal expansion from a single or limited number of cells normally located in that region. Whether Xmeis1b-induced cell masses result from pigmented cell dierentiation and/or proliferation is still under investigation.
Xmeis1a and Xmeis1b do not show cooperative activity
Recently, it has shown that the Meis protein and other homeobox-containing proteins, such as Pbx and Hox family proteins form trimeric complexes in vivo and augment the anity and speci®city of DNA binding (Chang et al., 1996 (Chang et al., , 1997 Ryoo et al., 1999; Lu et al., 1995; Neuteboom et al., 1995; Phelan et al., 1995; Berthelsen et al., 1998; Swift et al., 1998; Jacobs et al., 1999; Shanmugam et al., 1999; Shen et al., 1999) . Since Xmeis1a did show a weak ability to induce XGli-3, it was a possibility that the two alternatively spliced forms of Xmeis1 (Xmeis1a and Xmeis1b) may cooperate with each other to induce XZic gene expression. To test this hypothesis, we co-injected embryos with Xmeis1a and Xmeis1b, and examined the expression of XZic3 and Krox-20 in animal pole explants from these embryos. RT ± PCR analysis showed that neither XZic3 nor Krox-20 were induced above the levels observed when embryos were injected with either Xmeis1 transcript alone. However, the injection of high concentrations of Xmeis1b RNA (2.5 ng/embryo) induced both markers as expected (Figure 9a) .
Corresponding results pertaining to cell mass induction were obtained when we co-injected low doses of Xmeis1a (1.25 ng/embryo) and Xmeis1b (1.25 ng/embryo) RNA into two-cell stage embryos and allowed them to develop until stage 26. Co-injection of a low dose of Xmeis1a (1.25 ng/embryo) and Xmeis1b (1.25 ng/embryo) RNA induced ectopic cell masses in 28% of the injected embryos, compared with 24% of embryos injected with a low dose of Xmeis1b alone. Co-expression of Xmeis1a did not enhance the eect of Xmeis1b in whole embryos. As expected, injection of a high dose of Xmeis1b RNA induced cell masses in over 90% of embryos (Figure 9b ). These data suggest that Xmeis1a and Xmeis1b do not cooperate with each other to induce neural gene expression or the accompanying cell masses.
Xmeis1b induced neuronal, neural crest cell, and posterior neural tissue markers in the whole embryo
The preceding experiments performed in explants and whole embryos suggested that Xmeis1b may play a role in the speci®cation of neural crest cell fate. To discern whether Xmeis1b could in¯uence neural and neural crest cell markers in the developing embryo, we examined the expression of N-tubulin (a pan-neuronal marker), Krox-20 (a hindbrain and late neural crest marker), XAp-2 (a neural crest dierentiation marker), XSlug (an early neural crest marker), and XZic3 (a prepattern neural marker) in embryos unilaterally over- (Figure 10 ). Occasionally, there is a noticeable shift of endogenous N-tubulin expression laterally, perhaps due to expansion of the neural fold (Figure 10 ). The expression of Krox-20 in rhombomere 3 (r3) and rhombomere 5 (r5) was strongly expanded by the injection of Xmeis1b ( Figure  10 ). The expression in the r3 was expanded laterally, and the expression in the r5 was expanded along the anterior to posterior axis on the most lateral edge (Figure 10 ), but Krox-20 was not expressed in the region of the ectopic cell mass (data not shown). XAp-2 is expressed in the migrating neural crest cells at the tailbud stage, and the injection of Xmeis1b RNA enhanced the XAp-2 expression in the branchial arches ( Figure 10 ). In addition, ectopic XAp-2 expression was observed more caudally within the anterior portion of the spinal cord ( Figure 10 ). Ectopic expression was observed at the periphery of the protuberance, but not within the cell mass ( Figure 10 ). Since these three genes are commonly expressed in later stages of neural crest cell dierentiation, we next examined XSlug, an early neural crest marker, and XZic3, a pre-pattern neural crest gene. There was an observable expansion of XSlug expression on the Xmeis1b injected side, even at an early stage of development (stage 14). There was also a noticeable shift and enhancement of XZic3 expression in response to Xmeis1b, and ectopic XZic3 expression is detectable at the dorsal periphery of the cell mass (Figure 10 ). These alterations in gene expression may re¯ect the enhanced generation or migration of neural crest cells.
To test whether, Xmeis1 expression inhibited epidermal dierentiation, we examined the expression of the XK81A epidermal marker, a type I cytokeratin (Miyatani et al., 1986) . The cell mass of stage 18 embryos did not show hybridization to the XK81 probe, and there was a signi®cant reduction in type I keratin expression in the Xmeis1b-injected side of the embryo (Figure 10 ). Thus, Xmeis1b can either directly or indirectly inhibit epidermal dierentiation. Collectively, these results indicate that overexpression of Xmeis1b can induce ectopic neural crest tissue, lateral cell masses, and block normal epidermal dierentiation. The striking induction of ectopic neural crest cell markers, including the prepattern gene XZic3, suggested that the Xmeis1 protein may be capable of specifying neural crest cell fate.
Discussion
During development Xmeis1 transcripts are expressed early and may have a role in neural crest speci®cation. Both Xmeis1a and Xmeis1b mRNA, two alternatively spliced forms of Xmeis1, are maternal messages that are present through gastrulation ( Figure 1b) . As development progresses, Xmeis1 expression is broad, but found in the lateral and dorsal neural tissue. Xmeis1 expression becomes strong in the cephalic neural crest, and the dorsal portion of the neural tube from where neural crest cells emigrate (Mayor et al., 1999; LaBonne and Bronner-Fraser, 1999) . Neural crest cells are multipotential cells arising from the region where the neural plate borders the non-neural ectoderm (Mayor et al., 1999; LaBonne and BronnerFraser, 1999) . Several secreted factors including BMPs, FGFs, and Wnts have been implicated in the induction and maintenance of neural crest (Sasai and De Robertis, 1997; Mayor et al., 1999; LaBonne and Bronner-Fraser, 1999) . Xmeis1 is expressed early and in the appropriate place to function in neural crest patterning decisions however, Xmeis1 expression is not restricted to only the prospective neural crest regions at early neurulation stages.
The broad expression pattern that is observed for Xmeis1 by whole mount in situ hybridization includes Figure 9 Xmies1a and Xmeis1b do not show cooperative activity. (a) The animal pole region of two-cell stage embryos were injected with Xmeis1a RNA alone, Xmeis1b RNA alone, or Xmeis1a and Xmeis1b RNAs together at varying doses, and animal pole explants were excised at stage 9, and cultured until stage 24. RT ± PCR gene analysis was performed for XZic3, Krox-20, and EF-1a. High (2.5 ng/embryo) and Low (1.25 ng/embryo) RNA doses were injected into embryos. (b) The animal pole region of two-cell stage embryos were injected with Xmeis1a RNA alone, Xmeis1b RNA alone, or Xmeis1a and Xmeis1b together, and cultured until stage 26. Note that a low concentration of Xmeis1b induced only 24% of ectopic pigmented cell accumulation, and co-injection of Xmeis1a and Xmeis1b did not enhance the phenotype (28%) Xmeis1 specifies neural cell fate R Maeda et al the expression of alternatively spliced forms of Xmeis1.
As shown in Figure 1b Xmeis1b expression diverges from that of Xmeis1a and shows a marked increase during neurulation stages. Xmeis1a shows a more gradual increase that peaks at tailbud stages suggesting that Xmeis1b may be more likely to have a function in neurogenesis. Additionally, Xmeis1 has an early expression pattern similar to XZic3, a transcription factor that is believed to be involved in early neural crest patterning (Nakata et al., 1997 (Nakata et al., , 1998 . Since the mammalian and¯y Meis1 protein has been shown to be a cofactor with Pbx1 in forming complexes with Hox proteins (Lu et al., 1995; Neuteboom et al., 1995; Phelan et al., 1995; Chang et al., 1996 Chang et al., , 1997 , it is also possible that Xmeis1 binding partners may be important for the temporal and tissue speci®c restriction of Xmeis1 function. Thus, Xmeis1 may display a broad expression pattern, but possess Figure 10 Xmeis1b induced ectopic expression of neural crest markers and inhibition of epidermal dierentiation. Xmeis1b (2.5 ng/ embryo) was injected into one blastomere of two-cell stage albino embryos, and cultured until the neurula stage or tailbud stage. Whole mount in situ hybridization analysis was performed using N-tubulin (pan-neuronal marker), Krox-20 (rhombomere marker), XAp-2 (neural crest marker), XSlug (early neural crest marker), XZic3 (neural crest induction gene) and XK81A (epidermal speci®c marker) as probes. Brackets indicate the ectopic expression of these markers. Note the increased expression of neural and neural crest markers (N-tubulin, Krox-20, Xap-2, Xslug, and XZic3) and the ectopic expression more posteriorly along A-P axis. Also note the reduction of XK81A expression on the Xmeis1b-injected side restricted function depending upon which cofactors interact with a particular Xmeis1 splice variant during a speci®c stage in development. A functional analysis of Xmeis1 strengthens the hypothesis that Xmeis1b may be involved in neural crest speci®cation. Overexpression of Xmeis1b in embryonic explants and embryos induced the ectopic expression of neural, and neural crest markers ( Figures  3, 4, 5 and 10) . Animal cap assays revealed that Xmeis1b induced neural markers without inducing mesoderm, suggesting that Xmeis1b may directly specify a neural crest cell fate on ectodermal cells (Figure 3) . Xmeis1a, despite having the same homeodomain and amino terminal protein interaction domains as Xmeis1b, was substantially less eective at inducing most neural and neural crest transcripts, suggestive of a possible dierence in their functional targets. This is the ®rst demonstration of a dierence in the function mediated by these two alternative transcripts. Further evidence for a distinction in the function of the two Xmeis1 splice variants came from animal cap explants co-expressing Xmeis1a and Xmeis1b. Analysis of these explants demonstrated a failure to cooperatively induce gene expression in these explants (Figure 9 ).
Xmeis1b also shows signi®cant dierences in expression pattern and functional activities from that of Xmeis3, the only other Meis superfamily gene isolated from Xenopus. Xmeis3 plays a role in neural tissue patterning in embryogenesis, especially, in the anteroposterior patterning of the neural axis (Salzberg et al., 1999) . The expression pattern of both Xmeis1 and Xmeis3 were very similar in the tailbud stage where both transcripts were expressed in the hindbrain region, however, Xmeis3 expression ®rst appears at the mid-to late-gastrula stages and is not a maternal message. In contrast to the Xmeis1b-induced neural crest markers and pigmented cell masses in embryos, Xmeis3 over-expression shows no eect on anterior or pan-neural marker expression in animal caps (Salzberg et al., 1999) , and induces more posterior neural markers (HoxB9) as well as anterior truncations when over-expressed in embryos (Salzberg et al., 1999) . These data suggest a distinct role for Xmeis1b in neural development.
Since, the Xmeis1b expression pattern and overexpression studies revealed a possible link to neural crest speci®cation, it is important to consider where Xmeis1b may ®t into the scheme of neural crest induction. There is some similarity in the expression of Xmeis1 with some other neural crest inducing genes. For example, Xmeis1 expression overlaps with Wnts in the mid-gastrula to early-neurula stages (Wolda et al., 1993) . Wnt1 and 3A, like Xmeis1, are expressed in the dorsal portion of the neural tube, and Xwnt3A or Xwnt1 overexpression can posteriorize neuroectoderm cooperatively with noggin and induce Krox-20 (McGrew et al., 1997 Saint-Jennet et al., 1997) . Expressing a dominant inhibitory Wnt ligand reduces expression of these genes (McGrew et al., 1997) and inhibits early neural crest markers (La Bonne and Bronner-Fraser, 1998). However, Xmeis1 can induce neural crest markers in animal cap explants directly while, Wnt1 and Wnt3A require the explants to be neuralized ®rst (Saint-Jennet et al., 1997) . This result and the data showing that Wnt3A expression is detected after neural crest is speci®ed (Wolda et al., 1993; Mancilla and Mayor, 1996) , suggests the possibility that Wnt signaling may function downstream of Xmeis1 activity. Consistent with this hypothesis, we have found a lack of Xmeis1 induction in response to Xwnt3A over-expression in animal caps (data not shown).
Xmeis1 induces some of the early players in neural crest formation. We ®nd that overexpression of Xmeis1 in ectodermal explants induces XGli-3 and XZic3 expression, while XGli-1 is not aected (Figure 4) . Gli and Zic genes, like Xmeis1b, induce neural tissue in animal cap explants (Nakata et al., 1997; Ruizi Altaba, 1998; Brewster et al., 1998; Matise et al., 1998; Ding et al., 1998) and it is interesting that Xmeis1b induces XGli-3 which is normally expressed in dorsal neural tube from where neural crest emanates (Marine et al., 1997) , but does not induce XGli-1 which is found ventrally within the neural tube. Moreover, transverse sections revealed that Xmeis1b induced an accumulation of ectopic pigmented cells in the embryo, and pigmented cells are often derived from neural crest. This data suggests that the eect of Xmeis1b may be to contribute to the expansion of dorsal neural cell fate which shows enriched expression of XZic3 and XGli-3, but not ventral neural cell fate where XGli-1 is prominent. There are strong similarities in the spatial location and function of XZic3 and Xmeis1b genes. Both are expressed early and broadly in the neural plate, but become more restricted as neural crest speci®cation occurs. Both Xmeis1b and XZic3 also induce pigmented cell masses in developing embryos (Figure 6, Nakata et al., 1997) . Finally, activation of an Xmeis1bGR protein leads to the rapid induction of XZic3 when compared to other genes involved in neural crest development ( Figure 5) .
A cascade of gene regulation has recently been proposed where subsequent to the interaction of BMPs and other inhibitory signaling systems, the activation of XZic3 in the neural plate occurs. This in turn, leads to activation of Gli genes followed by Xiro genes and ®nally proneural genes (XASH-3, Xngnr-1 etc.). However, as XZic3 expression becomes more restricted within neural folds, it may work in conjunction with other factors to induce early neural crest genes, like XZic5 (Nakata et al., 2000) , Xsnail, Xslug, and Xtwist. One can envision that Xmeis1b (along with a binding partner like XPbx1) may activate this pre-pattern gene, that in turn, activates the early neural crest genes (perhaps with assistance from Wnt3A) that are normally found in the neural fold (Xsnail, Xtwist, Xslug) and may confer the neural crest characteristics, including the ability to migrate (reviewed by Mayor et al., 1999) . These early neural crest genes may then induce various dierentiation genes (Krox-20, Ephs, Ets, Ap-2, etc.) (Mayor et al., 1999) .
Is there a connection between neural crest induction and the formation of pigmented cell masses in Xmeis1b expressing embryos? The tumor-like projections that are induced by Xmeis1b over-expression are heavily in®ltrated with pigmented cells and display a neural crest-like character. These cell populations appear to be highly motile, and can be found along a path from the neural tube, between the somites and epidermis, to the lateral cell mass region. These cells have not been proven to be of neural crest origin, but they possess characteristics that are consistent with such an origin. Similar cell masses have been observed in embryos ectopically expressing a small number of genes that include the XZic family (Nakata et al., 1997 (Nakata et al., , 1998 , XGli-1 (Dahmane et al., 1997) , Xrel3 (Yang et al., 1998) , and XsoxD (Mizuseki et al., 1998) , as well as a dominant negative form of the tumor suppressor p53 (Wallingford et al., 1997) . Additionally, overexpression of XBF-1, a neural-speci®c transcription factor, inhibits dierentiation and promotes neuroectodermal cell proliferation in embryos (Hardcastle and Papalopulu, 2000) .
Gli genes are known to be mediators of Hedgehog signaling (Dahmane et al., 1997; Marigo et al., 1996; Sasaki et al., 1997) which is involved in human tumorigenesis (reviewed by Matise and Joyner, 1999; Wicking et al., 1999) . Both Gli-1 and Gli-3 have been implicated in human tumor formation, and Gli-3 is involved in several developmental disorders (Matise and Joyner, 1999; Wicking et al., 1999) . Our data suggests that Xmeis1 may function in a common signaling pathway with Gli-3 and Zic3, where Xmeis1 and possible binding partners (Hox and Pbx1) regulate XZic3 and then XGli-3 expression.
The mechanism of how these genes control growth and dierentiation, thus leading to possible disease states, is unclear (Ruiz i Altaba, 1999a,b; Wallingford, 1999) . Perhaps, it is the ability of Xmeis1 to augment proliferation or inhibit dierentiation that may underlie the enhanced generation of neural crest cells, and it is this property that plays a role in oncogenesis. It still remains to be determined which genes are direct targets of Xmeis1 function and whether these target genes are key players in neural crest induction and oncogenesis.
Materials and methods
Embryos
Wild-type or albino Xenopus laevis embryos were obtained by arti®cial insemination after induction of female with 300 i.u. of human chorionic gonadtropin and microinjected as described (Maeda et al., 1997) . Developmental stages were designated according to Nieuwkoop and Faber (1967) .
RNA injection and explants
Xenopus Meis1a and Meis1b cDNAs were subcloned into the vector pCS2+. The frame shift mutant of Xmeis1b was created via digestion with Eco109I and PshA1, followed by blunting with Klenow, and re-ligation. The Xmeis1bGR construct was generated by ligating the coding region of Xmeis1b to a fragment encoding the hormone binding domain of the human glucocorticoid receptor that had been derived from an pSP64T-Xbra-GR construct (Tada et al., 1997) . All pCS2+ constructs were linearized with NotI, while Xmeis1bGR plasmid was linearized with XbaI. Capped RNA was synthesized using SP6 polymerase according to the manufacturer's protocol (Message Machine; Ambion). The plasmid containing eFGF (pSP64T) was linearized with EcoRI and capped RNA was synthesized using SP6 polymerase. XZic3 (pCS2+) was linearized with Asp718 and capped RNA was synthesized using SP6 polymerase. Two blastomeres of dejellied embryos were injected with these RNAs at 2-cell stage in 3% Ficoll/0.56Modi®ed Barth Solution (MBS). Embryos were developed up to stage 8, animal cap explants were excised, and further cultured in 0.56MBS. For activin treatment, animal pole explants from uninjected embryos were excised at stage 8, and the explants were cultured in 0.56MBS containing 0.1% BSA and 12 ng/ ml human recombinant activin. Western analysis was performed as described below for embryos injected with new RNA preparations to ensure consistent equivalent protein expression.
Whole-mount in situ hybridization
A pCRII-vector containing Xmeis1a was linearized with SacI and digoxygenin-labeled riboprobe was synthesized using T7 polymerase (MegaScript kit; Ambion). Plasmids containing N-tubulin (Richter et al., 1988) , Xenopus Krox-20 (Bradley et al., 1993) , Xenopus Ap-2 (Winning et al., 1991) , Xenopus Slug (Mayor et al., 1995) , Xenopus Zic3 (Nakata et al., 1997) , and Xenopus type I keratin (Miyatani et al., 1986) were linearized with restriction enzymes (StuI for N-tubulin, EcoRI for XKrox-20, HindIII for Xap-2, EcoRI for XSlug, BamHI for XZic3, and EcoRI for Xkeratin), and digoxygenin-labeled riboprobes were synthesized using T3 (for N-tubulinand XZic3) or T7 (for XKrox-20, Xap-2, and XSlug) or SP6 (for Xkeratin) polymerase. Wholemount in situ hybridization was essentially done as described by Harland (1991) . Brie¯y, embryos were from in vitro fertilized albino eggs with albino sperm were ®xed in MEMFA buer (0.1 M MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO 4 , and 3.7% formaldehyde), dehydrated in 100% methanol and stored at 7208C until use. Embryos were treated with 100% ethanol overnight, then rehydrated in successive 5 min washes with 100% methanol, 75% methanol, 50% methanol, and 25% methanol/75% PTW (Phosphate buered saline 7.4 and 0.1% Tween-20), 100% PTW. No proteinase K treatment was applied, and four 5 min washes in 0.1 M triethanolamine pH 7.5 were performed. The last two washes included 12.5 ml of acetic anhydride. Four washes in PTW were performed and embryos were prehybridized in 1 ml of hybridization buer (50% formamide, 56SSC, 1 mg/ml Torula RNA, 100 mg/ml heparin, 16Denhardts, 0.1% Tween-20, 0.1% CHAPS, 10 mM EDTA) for 6 h at 608C. This solution was replaced with 0.5 ml of hybridization solution containing 1 mg/ml of digoxigenin labeled antisense or sense RNA and incubated overnight at 608C. The embryos were washed three times in 26SSC at 608C for 20 min each, then washed one time in 26SSC containing RNAse A (20 mg/ml), RNAse T1 (10 units/ml) at 378C for 30 min. Embryos were washed extensively in 0.26SSC at 608C, then maleic acid buer [Mab] (100 mM maleic acid, 150 mM NaCl pH 7.5) at room temperature. Non-speci®c antibody binding sites were blocked with Mab containing 2% BMB blocking reagent and 20% heat inactivated lamb serum for 2 h at room temperature. This solution was replaced with Mab (with 2% BMB block and 20% lamb serum) containing a 1 : 2000 dilution of anity puri®ed sheep anti-digoxigenin antibody coupled to alkaline phosphatase and incubated overnight at 48C. After ®ve washes over 5 h in Mab the embryos were washed in alkaline phosphatase buer (100 mM Tris pH 9.5, 50 mM MgCl 2 , 100 mM NaCl, 0.1% Tween-20, 5 mM levamisol). Embryos were placed in the BM-Purple (Boehringer Mannheim) chromogenic substrate with 2 mM levamisole for 3 h at room temperature. The reaction was stopped and the embryos were ®xed in either MEMFA (uncleared embryos) or Bouin's stain (1 g picric acid in 3.7% formaldehyde, 5% acetic acid) overnight. Background was removed by several washes in 70% buered ethanol (pH 7.5). Then these embryos were cleared with benzyl benzoate/benzyl alcohol (2 : 1). Photographs were taken under a dissecting microscope (Zeiss SV11) with a DKC-5000 digital camera (Nikon), and digital images were processed using Adobe Photoshop.
For transverse sections, the embryos were embedded in paran after whole-mount in situ hybridization and dehydration, and 30 mm sections were cut and mounted on sialynated slides without counterstain.
RT ± PCR assay
Total RNA from staged embryos was extracted by AGPC method (RNA isolation kit, Stratagene). Complementary DNA was synthesized from 500 ng total RNA. Polymerase chain reaction (PCR) for Xmeis1a and Xmeis1b primer was performed in 50 ml solution containing 1 ml of cDNA, 16Taq buer, 1.5 mM MgCl 2 , 0.2 mM each of dNTP, 350 ng of each primer and 1 U of AmpliTaq DNA polymerase (Perkin Elmer). The PCR program consisted of 948C for 1 min, 608C for 1.5 min, 728C for 1 min. After extension step (728C for 10 min), 10 ml of sample was loaded on 1% agarose gel. Primers and cycle number used for Xmeis1a and Xmeis1b were as follows: Xmeis1a, 5'-CAG-TTG-GCA-CAA-GAC-ACG-G-3' and 5'-GAT-GAA-AGT-TAC-ATG-TAG-TGC-C-3' for 28 cycles, Xmeis1b, 5'-CAG-TTG-GCA-CAA-GAC-ACC-G-3' and 5'-GCA-TAC-CTT-GCA-GTC-CCG-GTG-3' for 30 cycles. Extraction of total RNA from animal cap explants and reverse transcriptase-PCR assay were performed as described previously (Maeda et al., 1997) . The PCR reaction regarding XGli-1 was performed with following primers: 5'-AAC-CAT-GGG-GGT-CAT-GTG-CA-3' and 5'-TCT-GAG-ACC-TAC-GCC-CTG-GA-3' for 25 cycles with 558C annealing temperature. The primer sequences and conditions for N-CAM, N-tubulin, Otx-2, En-2, Krox-20, HoxB9, muscle actin, Xbra (Hemmati-Brivanlou, 1994), XZic3 (Nakata et al., 1997), XGli-3 (Marine et al., 1997), XASH-3 (Zimmerman et al., 1993) and EF-1a (Suzuki et al., 1993) have been previously published. Histone H4 and Xtwist primer sequences were posted at The Xenopus Molecular Marker Resource web page (http://vize222.zo.utexas. edu/). These experiments were repeated three times for consistency.
Histology
The embryos injected with Xmeis1b cultured to stage 22 or stage 26 were ®xed with Dent ®xative (20% DMSO in Methanol), embedded in paran, sectioned at 7 mm, and stained with hematoxylin and eosin.
Lineage tracing
Capped RNA for nuclear localized b-galactosidase was synthesized and co-injected with Xmeis1b RNA into one blastomere of an 8-cell stage ventral-animal blastomere. Embryos were cultured to stage 26, then ®xed with 1% paraformaldehyde, 0.2% glutaraldehyde, 0.02% NP-40 in Phosphate Buered Saline and enzymatic activity was detected with X-gal staining.
Western blot analysis
The embryos injected with Xmeis1a (2.5 ng/embryo) or Xmeis1b (2.5 ng/embryo) were cultured until stage 10. Embryos were solubilized with lysis buer (10 ml/embryo; 137 mM NaCl, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 1% NP-40 containing 1 : 50 diluted Calbiochem Protease Inhibitor Cocktail Set III), and supernatant was extracted with the same volume of Freon (1,2,2,-Trichlorotri¯uoroethane). Lysates from three embryos per sample were separated by 10% SDS ± PAGE. After the proteins were transferred to a polyvinylidene di¯uoride membrane (Immobilon-P, Millipore), the membrane was blocked with 5% non-fat dry milk in TBS containing 0.1% Tween-20 (TBST), and incubated with anti-Xmeis antibody (1 : 500 dilution) followed by peroxidase-conjugated secondary antibodies (1 : 20 000 dilution). Staining was visualized with an ECL assay (Amersham).
